Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNovacyt Share Price (NCYT)

Share Price Information for Novacyt (NCYT)

Share Price is delayed by 15 minutes
Get Live Data
38.80    -0.70 (-1.77%)
Bid:
38.80
Ask:
39.50
Spread: 0.70 (1.804%)
Market Cap: £28.11m
NCYT Live PriceLast checked at - London Stock Exchange

Intraday Novacyt Share Chart

Novacyt Share Price
Price 38.80 Open 39.40
Bid 38.80 High 39.50
Ask 39.50 Low 37.50
Change -0.70 (-1.77%) Close 39.50
Volume 177,096
Currency GBX
Issue Country GB
Shares in Issue 72.44m
Market Cap £28.11m
PE Ratio -1.2125
EPS -32.00
Year High 81.00
Year High Date 12-May-2026
Year Low 26.60
Year Low Date 05-May-2026
Dividend 0.00
Yield 0.00%
# Trades 45
Vol. Sold 78,333
Sold Value £30.05k
Vol. Bought 98,570
Bought Value £38.12k
Market Size 5,000
What if I invested £1,000 in Novacyt?
£ 830.84 (-16.92%)
1 month ago
£ 1,136.16 (+13.62%)
3 months ago
£ 998.71 (-0.13%)
6 months ago
£ 815.13 (-18.49%)
1 year ago
Add NCYT to WatchlistAdd NCYT to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Novacyt S.a. Eur1/15th (cdi)

Novacyt is listed in the FTSE AIM All-Share index.

Novacyt is listed in the Medical Services sector.

Novacyt S.a. Eur1/15th (cdi) is listed on the London Stock Exchange trading with ticker code NCYT.L. It has a market capitalisation of £28.11m, with approximately 72.44m shares in issue. Over the last year, Novacyt share price has been traded in a range of 54.40, hitting a high of 81.00, and a low of 26.60.

Novacyt is a UK-based global diagnostics company specialising in the development, manufacturing, and distribution of innovative diagnostic products and services. With a focus on infectious diseases, Novacyt provides advanced molecular diagnostic solutions that enable rapid and accurate testing. The company's diverse portfolio includes COVID-19 testing kits, respiratory pathogens detection assays, and oncology testing solutions. Novacyt's cutting-edge technologies and commitment to scientific excellence have positioned it as a trusted partner in the healthcare industry. Through its global presence and collaborative approach, Novacyt continues to make significant contributions to disease management and patient care worldwide.

Some Videos You Might Like

What's Hot in FTSE Reshuffl...


 

What's Hot 24th March 2026


Recent Share Trades for Novacyt (NCYT)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
08-Jun-2616:35:2738.80261Sell*38.8039.50101.27UT Uncrossing Trade
08-Jun-2616:11:0138.802328Sell*38.8039.5010.86O Ordinary
08-Jun-2615:53:1439.4025Buy*38.8039.409.85O Ordinary
Trade was executed as an SI
08-Jun-2614:05:3339.501,180Buy*38.8039.50466.10A Automatic Execution
08-Jun-2613:03:1038.4142Sell*38.2039.400.77O Ordinary
08-Jun-2610:57:1338.2064Unknown*38.2039.4024.45O Ordinary
Delayed publication
Was reported as OTC
08-Jun-2610:57:1238.20129Unknown*38.2039.4049.28O Ordinary
Delayed publication
Was reported as OTC
08-Jun-2610:47:4038.406,644Sell*38.4039.402,551A Automatic Execution
08-Jun-2610:26:1038.2018Sell*38.4039.006.88O Ordinary
Trade was executed as an SI
08-Jun-2610:12:2538.601,048Buy*37.6038.60404.53A Automatic Execution

Directors Deals for Novacyt (NCYT)

Announced Traded Action Notifier Price Currency Amount Holding
30-Mar-2627-Mar-26BuyIan David Gilham held the position of Non-Executive Director at the time of this trade.Ian David Gilham34.42GBX28,75028,750
30-Mar-2627-Mar-26BuyJohn Brown held the position of Non-Executive Chairman at the time of this trade.John Brown38.99GBX73,76273,762
30-Mar-2626-Mar-26BuyLyn Rees held the position of Chief Executive Officer at the time of this trade.Lyn Rees0.39EUR73,37973,379
15-Jul-2211-Jul-22Transfer ToEdwin Snape held the position of Independent Non-Executive Director at the time of this trade.Edwin Snape0.0017,91917,919
07-Jul-2207-Jul-22BuyJames Wakefield held the position of Non-Executive Chairman at the time of this trade.James Wakefield117.00GBX7,00043,839